BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37409718)

  • 1. Protective effect of manganese treatment on insulin resistance in HepG2 hepatocytes.
    Zhang Q; Song S; Jiang R; Zhang J; Na L
    Nutr Hosp; 2023 Aug; 40(4):746-754. PubMed ID: 37409718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artichoke (Cynara scolymus L.) water extract alleviates palmitate-induced insulin resistance in HepG2 hepatocytes via the activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β signaling pathway.
    Deng A; Wang Y; Huang K; Xie P; Mo P; Liu F; Chen J; Chen K; Wang Y; Xiao B
    BMC Complement Med Ther; 2023 Dec; 23(1):460. PubMed ID: 38102588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wheat germ peptide improves glucose metabolism and insulin resistance in HepG2 hepatocytes via regulating SOCS3/IRS1/Akt pathway.
    Song H; Huang Q; Zhang Y; Shen X
    Nutr Res; 2023 Dec; 120():135-144. PubMed ID: 38000279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diarylheptanoid compound from Alpinia officinarum Hance ameliorates high glucose-induced insulin resistance by regulating PI3K/AKT-Nrf2-GSK3β signaling pathways in HepG2 cells.
    Zhang XG; Liu AX; Zhang YX; Zhou MY; Li XY; Fu MH; Pan YP; Xu J; Zhang JQ
    J Ethnopharmacol; 2022 Sep; 295():115397. PubMed ID: 35605918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
    Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
    Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen-kidney supplementing formula alleviates insulin resistance via regulating AKT/glycogen synthase kinase 3β pathway in rats with type 2 diabetic induced by high-fat diet.
    Tian C; Wang Y; La X; Li J; Zhang B
    J Tradit Chin Med; 2019 Apr; 39(2):199-206. PubMed ID: 32186042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
    Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
    Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE
    Liang M; Wang L; Wang W
    Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
    Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
    Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of sitagliptin in palmitic acid-induced insulin resistance in human HepG2 cells through the suppressor of cytokine signaling 3/phosphoinositide 3-kinase/protein kinase B pathway.
    Ma R; Quan L; Aleteng QQ; Li L; Zhu J; Jiang S
    J Physiol Pharmacol; 2023 Apr; 74(2):. PubMed ID: 37453092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes.
    Fan X; Jiao G; Pang T; Wen T; He Z; Han J; Zhang F; Chen W
    Phytomedicine; 2023 Jun; 114():154740. PubMed ID: 36965373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent Hypoxia Disrupts Glucose Homeostasis in Liver Cells in an Insulin-Dependent and Independent Manner.
    Gu CJ; Yi HH; Feng J; Zhang ZG; Zhou J; Zhou LN; Zhou JP; Li M; Li QY
    Cell Physiol Biochem; 2018; 47(3):1042-1050. PubMed ID: 29843131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin-3-O-α-L-arabinopyranosyl-(1→2)-β-D-glucopyranoside Isolated from Eucommia ulmoides Leaf Relieves Insulin Resistance in HepG2 Cells via the IRS-1/PI3K/Akt/GSK-3β Pathway.
    Tang P; Tang Y; Liu Y; He B; Shen X; Zhang ZJ; Qin DL; Tian J
    Biol Pharm Bull; 2023 Feb; 46(2):219-229. PubMed ID: 36517007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loureirin B attenuates insulin resistance in HepG2 cells by regulating gluconeogenesis signaling pathway.
    Ding Y; Xia S; Fang H; Niu B; Chen Q
    Eur J Pharmacol; 2021 Nov; 910():174481. PubMed ID: 34481876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
    Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
    Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETNPPL modulates hyperinsulinemia-induced insulin resistance through the SIK1/ROS-mediated inactivation of the PI3K/AKT signaling pathway in hepatocytes.
    Chen X; Liu P; Zhang W; Li X; Wang C; Han F; Liu W; Huang Y; Li M; Li Y; Sun X; Fan X; Li W; Xiong Y; Qian L
    J Cell Physiol; 2023 May; 238(5):1046-1062. PubMed ID: 36924049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mn-SOD alleviates methotrexate-related hepatocellular injury via GSK-3β affecting anti-oxidative stress of HO-1 and Drp1.
    Li Z; Chen M; Wang W; Liu Q; Li N; He B; Jiang Y; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 47(9):1191-1199. PubMed ID: 36411702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of betatrophin enhances insulin sensitivity in type 2 diabetes mellitus through activation of the GSK-3β/PGC-1α signaling pathway.
    Hao Q; Zheng A; Zhang H; Cao H
    J Endocrinol Invest; 2021 Sep; 44(9):1857-1868. PubMed ID: 33464548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.